551 related articles for article (PubMed ID: 32585475)
1. Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
Thornton C; Dickson KE; Carty DR; Ashpole NM; Willett KL
Epilepsy Behav; 2020 Sep; 110():107152. PubMed ID: 32585475
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
Miller OS; Elder EJ; Jones KJ; Gidal BE
Epilepsy Behav; 2022 Feb; 127():108514. PubMed ID: 34998268
[TBL] [Abstract][Full Text] [Related]
3. Interactions between cannabidiol and Δ
Anderson LL; Low IK; McGregor IS; Arnold JC
Br J Pharmacol; 2020 Sep; 177(18):4261-4274. PubMed ID: 32608111
[TBL] [Abstract][Full Text] [Related]
4. Behavioral Comorbidities and Drug Treatments in a Zebrafish
Grone BP; Qu T; Baraban SC
eNeuro; 2017; 4(4):. PubMed ID: 28812061
[TBL] [Abstract][Full Text] [Related]
5. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of cannabinoids in the treatment of epilepsy.
Gaston TE; Friedman D
Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
[TBL] [Abstract][Full Text] [Related]
7. NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome.
Weuring WJ; Singh S; Volkers L; Rook MB; van 't Slot RH; Bosma M; Inserra M; Vetter I; Verhoeven-Duif NM; Braun KPJ; Rivara M; Koeleman BPC
PLoS One; 2020; 15(3):e0219106. PubMed ID: 32134913
[TBL] [Abstract][Full Text] [Related]
8. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
Niesink RJ; Rigter S; Koeter MW; Brunt TM
Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
[TBL] [Abstract][Full Text] [Related]
9. Cannabis sativa: Much more beyond Δ
Alves P; Amaral C; Teixeira N; Correia-da-Silva G
Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
[TBL] [Abstract][Full Text] [Related]
10. Phytocannabinoids Reduce Seizures in Larval Zebrafish and Affect Endocannabinoid Gene Expression.
Kollipara R; Langille E; Tobin C; French CR
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759798
[TBL] [Abstract][Full Text] [Related]
11. Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures.
Mascal M; Hafezi N; Wang D; Hu Y; Serra G; Dallas ML; Spencer JPE
Sci Rep; 2019 May; 9(1):7778. PubMed ID: 31123271
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
Golub V; Reddy DS
Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
[TBL] [Abstract][Full Text] [Related]
13. The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol.
Chesher GB; Jackson DM
Pharmacol Biochem Behav; 1985 Jul; 23(1):13-5. PubMed ID: 2994117
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids in treatment-resistant epilepsy: A review.
O'Connell BK; Gloss D; Devinsky O
Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
[TBL] [Abstract][Full Text] [Related]
15. Direct Quantitation of Phytocannabinoids by One-Dimensional
Dadiotis E; Mitsis V; Melliou E; Magiatis P
Molecules; 2022 May; 27(9):. PubMed ID: 35566314
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
Reddy DS
Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine.
Zhang Y; Kecskés A; Copmans D; Langlois M; Crawford AD; Ceulemans B; Lagae L; de Witte PA; Esguerra CV
PLoS One; 2015; 10(5):e0125898. PubMed ID: 25965391
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
19. Cannabis for the Treatment of Epilepsy: an Update.
Gaston TE; Szaflarski JP
Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of CBD, Δ
Jaidee W; Siridechakorn I; Nessopa S; Wisuitiprot V; Chaiwangrach N; Ingkaninan K; Waranuch N
Cannabis Cannabinoid Res; 2022 Aug; 7(4):537-547. PubMed ID: 34096805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
